The nutraceutical role of the Phaseolus vulgaris α-amylase inhibitor

British Journal of Nutrition

Volumn 100, Issue 1, 2008, Pages 1-12

  Obiro, Wokadala Cuthbert ^a   Zhang, Tao ^a   Jiang, Bo ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Amylase inhibitor; Common beans Phaseolus vulgaris); Diabetes; Hyperglycaemia; Obesity; Toxicity

Indexed keywords

ACARBOSE; AMYLASE; AMYLASE 1 INHIBITOR; AMYLASE INHIBITOR; ANTIOBESITY AGENT; BLOCKAL; INSULIN; NUTRACEUTICAL; PHASE 2; PLACEBO; STARCH; UNCLASSIFIED DRUG; VOGLIBOSE;

ABDOMINAL DISEASE; AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; CALORIC RESTRICTION; CARBOHYDRATE TOLERANCE; CLINICAL TRIAL; COLORECTAL CANCER; DIABETES MELLITUS; DRUG EFFICACY; DRUG ERUPTION; DRUG MECHANISM; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INCUBATION TIME; INSULIN BLOOD LEVEL; INTESTINE FLORA; NONHUMAN; OBESITY; PH; PHASEOLUS VULGARIS; PHYSICAL CHEMISTRY; REVIEW; SIDE EFFECT; STRUCTURE ACTIVITY RELATION; TEMPERATURE; TOXICITY TESTING; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; CHEMISTRY, PHYSICAL; DIABETES MELLITUS; DIETARY SUPPLEMENTS; HUMANS; HYPOGLYCEMIC AGENTS; OBESITY; PLANT LECTINS;

PHASEOLUS VULGARIS;

EID: 53049103273     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508879135     Document Type: Review

References (114)

1. Broughton WJ, Hernández G, Blair M, Beebe S, Gepts P & Vanderleyden J (2003) Beans (Phaseolus spp.) - model food legumes. Plant Soil 252, 55-128.
2. Champ MM (2002) Non-nutrient bioactive substances of pulses. Br J Nutr 88, 307-319.
3. Bowman DE (1945) Amylase inhibitor of navy bean. Science 102 358-359.
4. Celleno L, Tolaini MV, D'Amore A, Perricone NV & Preuss HG (2007) A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci 4, 45-52.
5. Chokshi D (2006) Toxicity studies of blockal, a dietary supplement containing Phase 2 starch neutralizer (Phase 2), a standardized extract of the common white kidney bean (Phaseolus vulgaris). Int J Toxicol 25, 361-371.
6. Layer P, Carlson GL & DiMagno EP (1985) Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Gastroenterology 88, 1895-1902.
7. Layer P, Zinsmeister AR & DiMagno EP (1986) Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology 91, 41-48.
8. Skop M & Chokshi D (2006) Purified amylase inhibitor and novel process for obtaining the same. http://www.freepatentsonline.com/ 20060147565.html (accessed 10 April 2007).
9. Goldstein DJ (1992) Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 16, 397-415.
10. Popkin BM & Doak CM (1998) The obesity epidemic is a worldwide phenomenon. Nutr Rev 56, 106-114.
11. Seidell JC (2000) Obesity, insulin resistance and diabetes: A worldwide epidemic. Br J Nutr 83, Suppl. 1, S5-S8.
12. James PT, Leach R, Kalamara E & Shayeghi M (2001) The worldwide obesity epidemic. Obes Res 9, 2288-2338.
13. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS & Marks JS (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289, 76-79.
14. Pariza M (1996) Toxic substances. In Food Chemistry, 3rd ed., pp. 825-840 [OR Fenema, editor]. New York: Marcel Dekker.
15. Pittler MH & Ernst E (2004) Dietary supplements for bodyweight reduction: A systematic review. Am J Clin Nutr 79, 529-536.
16. Food and Agricultural Organization (2005) FAOSTAT database http://faostat.fao.org/site/567/DesktopDefault.aspx?PageID=567 (accessed April 2007).
17. Kusaba-Nakayama M, Ki M, Iwamoto M, Shibata R, Sato M & Imaizumi K (2000) CM3, one of the wheat α-amylase inhibitor subunits, and binding of IgE in sera from Japanese with atopic dermatitis related to wheat. Food Chem Toxicol 38, 179-185.
18. Sanchez-Monge R, Garcia-Casado G, Lopez-Otin C, Armentia A & Salcedo G (1997) Wheat flour peroxidase is a prominent allergen associated with baker's asthma. Clin Exp Allergy 27, 1130-1137.
19. Garcia-Casado G, Armentia A, Sanchez-Monge R, Malpica JM & Salcedo G (1996) Rye flour allergens associated with baker's asthma. Correlation between in vivo and in vitro activities and comparison with their wheat and barley homologues. Clin Exp Allergy 26, 428-435.
20. Franco OL, Rigden DJ, Melo FR & Grossi-de-Sa MF (2002) Plant α-amylase inhibitors and their interaction with insect α-amylases; structure, function and potential for crop protection. FEBS J 269, 397-412.
21. Iguti AM & Lajolo FM (1991) Occurrence and purification of α-amylase isoinhibitors in bean (Phaseolus vulgaris L.) varieties. J Agric Food Chem 39, 2131-2136.
22. Ishimoto M, Suzuki K, Iwanaga M, Kikuchi F & Kitamura K (1995) Variation of seed α-amylase inhibitors in the common bean. Theor Appl Genet 90, 425-429.
23. Ishimoto M & Kitamura K (1991) Effect of absence of seed α-amylase inhibitor on the growth inhibitory activity to azuki bean weevil (Callosobruchus chinensis) in common bean (Phaseolus vulgaris L.). Jpn J Breed 41, 231-240.
24. Suzuki K, Ishimoto M, Kikuchi F & Kitamura K (1993) Growth inhibitory effect of an α-amylase inhibitor from the wild common bean resistant to the Mexican bean weevil (Zabrotes subfasciatus). Jpn J Breed 43 257-265.
25. Moreno J, Altabella T & Chrispeels MJ (1990) Characterization of α-amylase inhibitor, a lectin-like protein in the seeds of Phaseolus vulgaris L. Plant Physiol 92, 703-709.
26. Moreno J & Chrispeels MJ (1989) A lectin gene encodes the α-amylase inhibitor of the common bean. Proc Natl Acad Sci U S A 86, 7885-7889.
27. Pueyo JJ, Hunt DC & Chrispeels MJ (1993) Activation of bean (Phaseolus vulgaris) α-amylase inhibitor requires proteolytic processing of the proprotein. Plant Physiol 101, 1341-1348.
28. Young NM & Oomen RP (1992) Analysis of sequence variation among legume lectins. A ring of hypervariable residues forms the perimeter of the carbohydrate-binding site. J Mol Biol 228, 924-934.
29. Lee SC, Gepts PL & Whitaker JR (2002) Protein structures of common bean (Phaseolus vulgaris) α-amylase inhibitors. J Agric Food Chem 50, 6618-6627.
30. Finardi-Filho F, Mirkov TE & Chrispeels MJ (1996) A putative precursor protein in the evolution of the bean α-amylase inhibitor. Phytochemistry 43, 57-62.
31. Islam FMA, Basford KE, Redden RJ, Gonzalez AV, Kroonenberg PM & Beebe S (2002) Genetic variability in cultivated common bean beyond the two major gene pools. Genet Resour Crop Evol 49, 271-283.
32. Marshall JJ & Lauda CM (1975) Purification and properties of phaseolamin, an inhibitor of α-amylase, from the kidney bean, Phaseolus vulgaris. J Biol Chem 250, 8030-8037.
33. Sparvoli F, Lanave C, Santucci A, Bollini R & Lioi L (2001) Lectin and lectin-related proteins in lima bean (Phaseolus lunatus L.) seeds: biochemical and evolutionary studies. Plant Mol Biol 45, 587-597.
34. Ishimoto M, Yamada T & Kaga A (1999) Insecticidal activity of an α-amylase inhibitor-like protein resembling a putative precursor of α-amylase inhibitor in the common bean, Phaseolus vulgaris L. Biochim Biophys Acta 1432, 104-112.
35. Le Berre-Anton V, Nahoum V, Payan F & Rouge P (2000) Molecular basis for the specific binding of different α-amylase inhibitors from Phaseolus vulgaris seeds to the active site of α-amylase. Plant Physiol Biochem 38, 657-665.
36. Santino A, Daminati MG, Vitale A & Bollini R (1992) The α-amylase inhibitor of bean seed: Two step proteolytic maturation in the protein storage vacuoles of the developing cotyledon. Physiol Plant 85 425-432.
37. Young NM, Thibault P, Watson DC & Chrispeels MJ (1999) Post-translational processing of two α-amylase inhibitors and an arcelin from the common bean, Phaseolus vulgaris. FEBS Lett 446 203-206.
38. Santimone M, Koukiekolo R, Moreau Y, Le Berre V, Rouge P, Marchis-Mouren G & Desseaux V (2004) Porcine pancreatic α-amylase inhibition by the kidney bean (Phaseolus vulgaris) inhibitor (α-AI1) and structural changes in the α-amylase inhibitor complex. Biochim Biophys Acta 1696, 181-190.
39. Higaki H & Yamaguchi H (1994) Reconstitution of Phaseolus vulgaris α-amylase inhibitor from isolated subunits. Biosci Biotechnol Biochem 58, 5-8.
40. Sawada S, Takeda Y & Tashiro M (2002) Primary structures of α- and ß-subunits of α-amylase inhibitors from seeds of three cultivars of Phaseolus beans. J Protein Chem 21, 9-17.
41. Gibbs BF & Alli I (1998) Characterization of a purified α-amylase inhibitor from white kidney beans (Phaseolus vulgaris). Food Res Int 31, 217-225.
42. Bompard-Gilles C, Rousseau P, Rouge P & Payan F (1996) Substrate mimicry in the active center of a mammalian α-amylase: Structural analysis of an enzyme-inhibitor complex. Structure 4, 1441-1452.
43. Kluh I, Horn M, Hyblova J, Hubert J, Doleckova-Maresova L, Voburka Z, Kudlikova I, Kocourek F & Mares M (2005) Inhibitory specificity and insecticidal selectivity of α-amylase inhibitor from Phaseolus vulgaris. Phytochemistry 66, 31-39.
44. Kasahara K, Hayashi K, Arakawa T, Philo JS, Wen J, Hara S & Yamaguchi H (1996) Complete sequence, subunit structure and complexes with pancreatic α-amylase of an α-amylase inhibitor from Phaseolus vulgaris white kidney beans. J Biochem 120, 177-183.
45. Koukiekolo R, Desseaux V, Moreau Y, Marchis-Mouren G & Santimone M (2001) Mechanism of porcine pancreatic α-amylase inhibition of amylose and maltopentaose hydrolysis by α-, β-and γ-cyclodextrins. Eur J Biochem 268, 841-848.
46. Koukiekolo R, Le Berre-Anton V, Desseaux V, Moreau Y, Rouge P, Marchis-Mouren G & Santimone M (1999) Mechanism of porcine pancreatic α-amylase inhibition of amylose and maltopentaose hydrolysis by kidney bean (Phaseolus vulgaris) inhibitor and comparison with that by acarbose. Eur J Biochem 265, 20-26.
47. Lee SC & Whitaker JR (2000) The molecular weight of α-amylase inhibitior from white bean cv 858B (Phaseolus vulgaris L.) is 56 kDa, not 20 kDa. J Food Biochem 24, 55-67.
48. Le Berre-Anton V, Bompard-Gilles C, Payan F & Rouge P (1997) Characterization and functional properties of the α-amylase inhibitor (α-AI) from kidney bean (Phaseolus vulgaris) seeds. Biochim Biophys Acta 1343, 31-40.
49. Lajolo FM & Finardi Filho F (1985) Partial characterization of the amylase inhibitor of black beans (Phaseolus vulgaris), variety Rico 23. J Agric Food Chem 33, 132-138.
50. Kotaru M, Yoshikawa H, Ikeuchi T, Saito K, Iwami K & Ibuki F (1987) An α-amylase inhibitor from cranberry bean (Phaseolus vulgaris): Its specificity in inhibition of mammalian pancreatic α-amylases and formation of a complex with the porcine enzyme. J Nutr Sci Vitaminol (Tokyo) 33, 359-367.
51. Powers JR & Whitaker JR (1977) Effect of several experimental parameters on combination of red kidney bean (Phaseolus vulgaris) α-amylase inhibitor with porcine pancreatic α-amylase. J Food Biochem 1 239-260.
52. Valencia A, Bustillo AE, Ossa GE & Chrispeels MJ (2000) α-Amylases of the coffee berry borer (Hypothenemus hampei) and their inhibition by two plant amylase inhibitors. Insect Biochem Mol Biol 30, 207-213.
53. Collins CL, Eason PJ, Dunshea FR, Higgins TJV & King RH (2006) Starch but not protein digestibility is altered in pigs fed transgenic peas containing α-amylase inhibitor. J Sci Food Agric 86, 1894-1899.
54. Payan F (2004) Structural basis for the inhibition of mammalian and insect α-amylases by plant protein inhibitors. Biochim Biophys Acta 1696, 171-180.
55. Nahoum V, Roux G, Anton V, Rougé P, Puigserver A, Bischoff H, Henrissat B & Payan F (2000) Crystal structures of human pancreatic α-amylase in complex with carbohydrate and proteinaceous inhibitors. Biochem J 346, 201-208.
56. Maurus R, Begum A, Kuo HH, Racaza A, Numao S, Andersen C, Tams JW, Vind J, Overall CM & Withers SG (2005) Structural and mechanistic studies of chloride induced activation of human pancreatic α-amylase. Protein Sci 14, 743-755.
57. Ho MF & Whitaker JR (1993) Subunit structures and essential amino acid residues of white kidney bean (Phaseolus vulgaris) α-amylase inhibitors. J Food Biochem 17, 35-52.
58. Mirkov TE, Evans SV, Wahlstrom J, Gomez L, Young NM & Chrispeels MJ (1995) Location of the active site of the bean α-amylase inhibitor and involvement of a Trp, Arg, Tyr triad. Glycobiology 5, 45-50.
59. Takahashi T, Hiramoto S, Wato S, Nishimoto T, Wada Y, Nagai K & Yamaguchi H (1999) Identification of essential amino acid residues of an α-amylase inhibitor from Phaseolus vulgaris white kidney beans. J Biochem 126, 838-844.
60. Da Silva MCM, De Sá MFG, Chrispeels MJ, Togawa RC & Neshich G (2000) Analysis of structural and physico-chemical parameters involved in the specificity of binding between α-amylases and their inhibitors. Protein Eng Des Sel 13, 167-177.
61. Qian M (1997) Structure of a pancreatic α-amylase bound to a substrate analogue at 2.03 A resolution. Protein Sci 6, 2285-2296.
62. Wilcox ER & Whitaker JR (1984) Some aspects of the mechanism of complexation of red kidney bean α-amylase inhibitor and α-amylase. Biochemistry 23, 1783-1791.
63. Brugge WR & Rosenfeld MS (1987) Impairment of starch absorption by a potent amylase inhibitor. Am J Gastroenterol 82, 718-722.
64. Boivin M, Zinsmeister AR, Go VL & DiMagno EP (1987) Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans. Mayo Clin Proc 62, 249-255.
65. Jain NK, Boivin M, Zinsmeister AR, Brown ML, Malagelada JR & DiMagno EP (1989) Effect of ileal perfusion of carbohydrates and amylase inhibitor on gastrointestinal hormones and emptying. Gastroenterology 96 377-387.
66. Jain NK, Boivin M, Zinsmeister AR & DiMagno EP (1991) The ileum and carbohydrate-mediated feedback regulation of postprandial pancreaticobiliary secretion in normal humans. Pancreas 6, 495-505.
67. Hollenbeck CB (1983) Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies. Am J Clin Nutr 38, 498-503.
68. Carlson GL, Li BU, Bass P & Olsen WA (1983) A bean α-amylase inhibitor formulation (starch blocker) is ineffective in man. Science 219 393.
69. Bo-Linn GW, Santa Ana CA, Morawski SG & Fordtran JS (1982) Starch blockers - their effect on calorie absorption from a high-starch meal. N Engl J Med 307, 1413-1416.
70. Liener IE & Tarcza JC (1984) Starch blockers: A potential source of trypsin inhibitors and lectins. Am J Clin Nutr 39, 196-200.
71. Kilpatrick DC, Green C & Yap PL (1983) Lectin content of slimming pills. BMJ (Clin Res Ed) 286, 305.
72. Menezes EW & Lajolo FM (1987) Inhibition of starch digestion by a black bean α-amylase inhibitor, in normal and diabetic rats. Nutr Rep Int 36, 1185-1195.
73. Kotaru M, Iwami K, Yeh HY & Ibuki F (1989) In vivo action of α-amylase inhibitor from cranberry bean (Phaseolus vulgaris in rat small intestine. J Nutr Sci Vitaminol (Tokyo) 35, 579-588.
74. Yoshikawa H, Kotaru M, Tanaka C, Ikeuchi T & Kawabata M (1999) Characterization of kintoki bean (Phaseolus vulgaris) α-amylase inhibitor: Inhibitory activities against human salivary and porcine pancreatic α-amylases and activity changes by proteolytic digestion. J Nutr Sci Vitaminol (Tokyo) 45, 797-802.
75. Kotaru M, Iwami K, Yeh HYU & Ibuki F (1991) Resistance of cranberry bean (Phaseolus vulgaris) α-amylase inhibitor to intraluminal digestion and its movement along rat gastrointestine: Further investigation using a radioactive probe and specific antiserum. Food Chem 42, 29-37.
76. Yanovski JA & Yanovski SZ (1998) Treatment of pediatric and adolescent obesity. Pediatrics 101, 554-570.
77. Harikumar KB, Jesil AM, Sabu MC & Kuttan R (2005) A preliminary assessment of the acute and subchronic toxicity profile of Phase 2: An α-amylase inhibitor. Int J Toxicol 24, 95-102.
78. Itoh T, Kita N, Kurokawa Y, Kobayashi M, Horio F & Furuichi Y (2004) Suppressive effect of a hot water extract of Adzuki beans (Vigna angularis) on hyperglycemia after sucrose loading in mice and diabetic rats. Biosci Biotechnol Biochem 68, 2421-2426.
79. Pusztai A, Grant G, Buchan WC, Bardocz S, De Carvalho AF & Ewen SW (1998) Lipid accumulation in obese Zucker rats is reduced by inclusion of raw kidney bean (Phaseolus vulgaris) in the diet. Br J Nutr 79, 213-221.
80. Hangen L & Bennink MR (2002) Consumption of black beans and navy beans (Phaseolus vulgaris) reduced azoxymethane-induced colon cancer in rats. Nutr Cancer 44, 60-65.
81. Tormo MA, Gil-Exojo I, De Tejada RA & Campillo JE (2006) White bean amylase inhibitor administered orally reduces glycaemia in type 2 diabetic rats. Br J Nutr 96, 539-544.
82. Tormo MA, Gil-Exojo I, De Tejada RA & Campillo JE (2004) Hypoglycaemic and anorexigenic activities of an α-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats. Br J Nutr 92 785-790.
83. Maranesi M, Carenini G & Gentili P (1984) Nutritional studies on anti-α-amylase. I. Influence on the growth rate, blood picture and biochemistry and histological parameters in rats. Acta Vitaminol Enzymol 6, 259-269.
84. Chokshi D (2007) Subchronic oral toxicity of a standardized white kidney bean (Phaseolus vulgaris) extract in rats. Food Chem Toxicol 45, 32-40.
85. Meiss DE & Ballerini R (2003) Effectiveness of Phase 2™, a natural α-amylase inhibitor, for weight loss: A randomized double-blind, placebo-controlled study Presented at Scripps Clinic Natural Supplements in Evidence-Based Practice Conference, 18 January 2003. La Jolla, CA: Scripps Clinic
86. Udani J, Hardy M & Madsen DC (2004) Blocking carbohydrate absorption and weight loss: A clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altern Med Rev 9, 63-69.
87. Diaz BE, Aguirre PC & Gotteland RM (2004) Effect of an amylase inhibitor on body weight reduction in obese women. Rev Chil Nutr 31, 306-317.
88. Pusztai A, Grant G, Duguid T, Brown DS, Peumans WJ, Van Damme EJ & Bardocz S (1995) Inhibition of starch digestion by α-amylase inhibitor reduces the efficiency of utilization of dietary proteins and lipids and retards the growth of rats. J Nutr 125, 1554-1562.
89. Udani K (2005) Product development of baked goods with a proprietary fractionated white bean extract. Agro Food Industry Hi Tech 16 20-22.
90. Udani K (2006) Development of baked goods with a new proprietary fractionated white bean extract (FWBE) to reduce carbohydrate absorption Prepared Foods 2006 R & D Applications Seminar, Itasca, IL. http://www.preparedfoods.com/CDA/HTML/eLearning/Presentations06/ BNP_GUID_9-5-2006_A_10000000000000026129 (accessed 25 October 2007).
91. Marzo F, Alonso R, Urdaneta E, Arricibita FJ & Ibanez F (2002) Nutritional quality of extruded kidney bean (Phaseolus vulgaris L. var. Pinto) and its effects on growth and skeletal muscle nitrogen fractions in rats. J Anim Sci 80, 875-879.
92. Higuchi M, Suga M & Iwai K (1983) Participation of lectin in biological effects of raw winged bean seeds on rats. Agric Biol Chem 47 1879-1886.
93. Pusztai A, Oliveira JTA, Bardocz S, Grant G & Wallace HM (1988) Dietary kidney bean lectin-induced hyperplasia and increased polyamine content of the small intestine. In Lectins, Biology, Biochemistry and Clinical Biochemistry, Vol. 6, 117-120 [TC Bog-Hansen and DLJ Freed, editors]. Lectins, Biology, Biochemistry and Clinical Biochemistry St Louis, MO: Sigma Chemical Company.
94. Cavallé de Moya C, Grant G, Frühbeck G, Urdaneta E, Garciá M, Marzo F & Santidrián S (2003) Local (gut) and systemic metabolism of rats is altered by consumption of raw bean (Phaseolus vulgaris L. var. athropurpurea). Br J Nutr 89, 311-318.
95. Salgado P, Montagne L, Freire JPB, Ferreira RB, Teixeira A, Bento O, Abreu MC, Toullec R & Lalles JP (2002) Legume grains enhance ileal losses of specific endogenous serine-protease proteins in weaned pigs. J Nutr 132, 1913-1920.
96. Carmalt J, Rosel K, Burns T & Janzen E (2003) Suspected white kidney bean (Phaseolus vulgaris) toxicity in horses and cattle. Aust Vet J 81, 674-676.
97. United States Food and Drug Administration Center for Food Safety and Applied Nutrition (2001) Food borne pathogenic microorganisms and natural toxins handbook http://vm.cfsan.fda.gov/~mow/intro.html (accessed April 2007).
98. Sockett PN, Cowden JM, Le Baigue S, Ross D, Adak GK & Evans H (1993) Foodborne disease surveillance in England and Wales: 1989-1991. Commun Dis Rep CDR Rev 3, R159-R173.
99. Grant G, More LJ, McKenzie NH, Stewart JC & Pusztai A (1983) A survey of the nutritional and haemagglutination properties of legume seeds generally available in the UK. Br J Nutr 50, 207-214.
100. Lioi L, Sparvoli F & Bollini R (1999) Variation and genomic polymorphism of lectin-related proteins in Lima bean (Phaseolus lunatus L.) seeds. Genet Resour Crop Evol 46, 175-182.
101. Burbano C, Muzquiz M, Ayet G, Cuadrado C & Pedrosa MM (1999) Evaluation of antinutritional factors of selected varieties of Phaseolus vulgaris. J Sci Food Agric 79, 1468-1472.
102. Sgarbieri VC (1989) Nutritional values of cereal products, beans and starches. World Rev Nutr Diet 60, 132-198.
103. Topping DL, Fukushima M & Bird AR (2007) Resistant starch as a prebiotic and symbiotic: State of the art. Proc Nutr Soc 62, 171-176.
104. Sajilata MG, Singhal RS & Kulkarni PR (2006) Resistant starch - a review. CRFSFS 5, 1-17.
105. Haralampu SG (2000) Resistant starch - a review of the physical properties and biological impact of RS3. Carbohydr Polymer 41 285-292.
106. Nugent AP (2005) Health properties of resistant starch. Nutr Bull 30, 27-54.
107. Topping DL & Clifton PM (2001) Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81, 1031-1064.
108. Le Leu RK, Brown IL, Hu Y & Young GP (2003) Effect of resistant starch on genotoxin-induced apoptosis, colonic epithelium, and lumenal contents in rats. Carcinogenesis 24, 1347-1352.
109. Le Leu RK, Brown IL, Hu Y, Bird AR, Jackson M, Esterman A & Young GP (2005) A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. J Nutr 135, 996-1001.
110. Macfarlane S & Macfarlane GT (2007) Regulation of short-chain fatty acid production. Proc Nutr Soc 62, 67-72.
111. Wolin MJ, Miller TL, Yerry S, Zhang Y, Bank S & Weaver GA (1999) Changes of fermentation pathways of fecal microbial communities associated with a drug treatment that increases dietary starch in the human colon. Appl Environ Microbiol 65, 2807-2812.
112. Wolever TM & Chiasson JL (2000) Acarbose raises serum butyrate in human subjects with impaired glucose tolerance. Br J Nutr 84, 57-61.
113. Weaver GA, Tangel CT, Krause JA, Parfitt MM, Jenkins PL, Rader JM, Lewis BA, Miller TL & Wolin MJ (1997) Acarbose enhances human colonic butyrate production. J Nutr 127, 717-723.
114. Holt PR, Atillasoy E, Lindenbaum J, Ho SB, Lupton JR, McMahon D & Moss SF (1996) Effects of acarbose on fecal nutrients, colonic pH, and short-chain fatty acids and rectal proliferative indices. Metabolism 45, 1179-1187.